表紙
市場調査レポート

扁平上皮非小細胞肺がん:世界の治験レビュー

Squamous Non-Small Cell Lung Carcinoma Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 300506
出版日 ページ情報 英文 150 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.18円で換算しております。
Back to Top
扁平上皮非小細胞肺がん:世界の治験レビュー Squamous Non-Small Cell Lung Carcinoma Global Clinical Trials Review, H1, 2014
出版日: 2014年04月24日 ページ情報: 英文 150 Pages
概要

当レポートでは、扁平上皮非小細胞肺がんに関する臨床研究の最新動向について分析し、疾患・治療法の概要や、主な先進国・新興国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、概略以下の構成でお届けします。

目次

イントロダクション

  • 扁平上皮非小細胞肺がん
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域上位5ヶ国における治験件数
    • 欧州上位5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:腫瘍全体に対する比率

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:腫瘍全体に対する比率

E7諸国での治験件数:フェーズ(相)別

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ別

進捗状況別の治験件数

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

  • 扁平上皮非小細胞肺がん治療薬の治験に参加している上位企業

有望な薬剤

治験のプロファイル

  • 代表的企業の治験の概要
    • Sun Farm Corporation
    • SCRI Development Innovations, LLC
    • Pfizer Inc.
    • Eli Lilly and Company
    • C. H. Boehringer Sohn AG & Co. KG
    • Bayer AG
    • Amgen Inc.
  • 代表的な研究機関・病院の治験の概要
    • Seoul Veterans Hospital
    • Washington Hospital Center
    • Ottawa Hospital Research Institute
    • Sarah Cannon Research Institute
    • UCLA's Jonsson Comprehensive Cancer Center
    • North Central Cancer Treatment Group
    • National Cancer Institute
    • The University of Texas M. D. Anderson Cancer Center

5つの代表的な治験のプロファイル

付録

図表一覧

目次
Product Code: GDHC2106CTIDB

GlobalData's clinical trial report, "Squamous Non-Small Cell Lung Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Squamous Non-Small Cell Lung Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Squamous Non-Small Cell Lung Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Squamous Non-Small Cell Lung Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Squamous Non-Small Cell Lung Carcinoma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Squamous Non-Small Cell Lung Carcinoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Squamous Non-Small Cell Lung Carcinoma to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Squamous Non-Small Cell Lung Carcinoma
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Sun Farm Corporation
      • Clinical Trial Overview of Sun Farm Corporation
      • SCRI Development Innovations, LLC
      • Clinical Trial Overview of SCRI Development Innovations, LLC
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Seoul Veterans Hospital
      • Clinical Trial Overview of Seoul Veterans Hospital
      • Washington Hospital Center
      • Clinical Trial Overview of Washington Hospital Center
      • Ottawa Hospital Research Institute
      • Clinical Trial Overview of Ottawa Hospital Research Institute
      • Sarah Cannon Research Institute
      • Clinical Trial Overview of Sarah Cannon Research Institute
      • UCLA's Jonsson Comprehensive Cancer Center
      • Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center
      • North Central Cancer Treatment Group
      • Clinical Trial Overview of North Central Cancer Treatment Group
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials by Region, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Squamous Non-Small Cell Lung Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Squamous Non-Small Cell Lung Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Farm Corporation, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by SCRI Development Innovations, LLC, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul Veterans Hospital, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington Hospital Center, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Treatment Group, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*

List of Figures

  • Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Squamous Non-Small Cell Lung Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Squamous Non-Small Cell Lung Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Squamous Non-Small Cell Lung Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top